Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
24.20
-0.06 (-0.25%)
Aug 5, 2025, 4:00 PM - Market closed
CALT Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $3.06 billion as of August 5, 2025. Its market cap has decreased by -33.70% in one year.
Market Cap
3.06B
Enterprise Value
3.15B
1-Year Change
-33.70%
Ranking
Category
Stock Price
$24.20
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $3.06B, an increase of 342.24%. That is a compound annual growth rate of 21.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 3.06B | -23.01% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 24.22% |
| Dec 31, 2021 | 4.60B | 6.25% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |